EU5 Metabolic Disorders Market Outlook to 2036 - Diabetes Assays and Cholesterol Tests

1.1 What Is This Report About?
1.2 Metabolic Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report

2.1 Metabolic Disorders Market, EU5, Revenue ($m), 2024-2036
2.2 Metabolic Disorders Market, EU5, Revenue ($m), 2024-2036
2.3 Metabolic Disorders Market, EU5, Volume (Units), 2024-2036
2.4 Metabolic Disorders Market, EU5, Volume (Units), 2024-2036
2.5 Metabolic Disorders Market, EU5, Company Share by Revenue ($m), 2025

3.1 Metabolic Disorders Market, France, Revenue ($m), 2024-2036
3.1.1 Cholesterol Tests Market, France, Revenue ($m), by Segment, 2024-2036
3.1.2 Diabetes Assays Market, France, Revenue ($m), by Segment, 2024-2036
3.2 Metabolic Disorders Market, France, Volume (Units), 2024-2036
3.2.1 Cholesterol Tests Market, France, Volume (Units), by Segment, 2024-2036
3.2.2 Diabetes Assays Market, France, Volume (Units), by Segment, 2024-2036
3.3 Metabolic Disorders Market, France, Average Price ($), 2024-2036
3.4 Metabolic Disorders Market, France, Company Share by Revenue ($m), 2025

4.1 Metabolic Disorders Market, Germany, Revenue ($m), 2024-2036
4.1.1 Cholesterol Tests Market, Germany, Revenue ($m), by Segment, 2024-2036
4.1.2 Diabetes Assays Market, Germany, Revenue ($m), by Segment, 2024-2036
4.2 Metabolic Disorders Market, Germany, Volume (Units), 2024-2036
4.2.1 Cholesterol Tests Market, Germany, Volume (Units), by Segment, 2024-2036
4.2.2 Diabetes Assays Market, Germany, Volume (Units), by Segment, 2024-2036
4.3 Metabolic Disorders Market, Germany, Average Price ($), 2024-2036
4.4 Metabolic Disorders Market, Germany, Company Share by Revenue ($m), 2025

5.1 Metabolic Disorders Market, Italy, Revenue ($m), 2024-2036
5.1.1 Cholesterol Tests Market, Italy, Revenue ($m), by Segment, 2024-2036
5.1.2 Diabetes Assays Market, Italy, Revenue ($m), by Segment, 2024-2036
5.2 Metabolic Disorders Market, Italy, Volume (Units), 2024-2036
5.2.1 Cholesterol Tests Market, Italy, Volume (Units), by Segment, 2024-2036
5.2.2 Diabetes Assays Market, Italy, Volume (Units), by Segment, 2024-2036
5.3 Metabolic Disorders Market, Italy, Average Price ($), 2024-2036
5.4 Metabolic Disorders Market, Italy, Company Share by Revenue ($m), 2025

6.1 Metabolic Disorders Market, Spain, Revenue ($m), 2024-2036
6.1.1 Cholesterol Tests Market, Spain, Revenue ($m), by Segment, 2024-2036
6.1.2 Diabetes Assays Market, Spain, Revenue ($m), by Segment, 2024-2036
6.2 Metabolic Disorders Market, Spain, Volume (Units), 2024-2036
6.2.1 Cholesterol Tests Market, Spain, Volume (Units), by Segment, 2024-2036
6.2.2 Diabetes Assays Market, Spain, Volume (Units), by Segment, 2024-2036
6.3 Metabolic Disorders Market, Spain, Average Price ($), 2024-2036
6.4 Metabolic Disorders Market, Spain, Company Share by Revenue ($m), 2025

7.1 Metabolic Disorders Market, United Kingdom, Revenue ($m), 2024-2036
7.1.1 Cholesterol Tests Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.1.2 Diabetes Assays Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.2 Metabolic Disorders Market, United Kingdom, Volume (Units), 2024-2036
7.2.1 Cholesterol Tests Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.2.2 Diabetes Assays Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.3 Metabolic Disorders Market, United Kingdom, Average Price ($), 2024-2036
7.4 Metabolic Disorders Market, United Kingdom, Company Share by Revenue ($m), 2025

8.1 Metabolic Disorders Market Pipeline Products
8.2 Metabolic Disorders - Pipeline Products by Stage of Development
8.3 Metabolic Disorders - Pipeline Products by Segment
8.4 Metabolic Disorders - Pipeline Products by Territory
8.5 Metabolic Disorders - Pipeline Products by Regulatory Path
8.6 Metabolic Disorders - Pipeline Products by Estimated Approval Date

9.1 Roche Diagnostics International Ltd
9.1.1 Company Overview
9.2 Siemens Healthineers AG
9.2.1 Company Overview
9.3 Abbott Laboratories
9.3.1 Company Overview
9.4 Beckman Coulter Inc
9.4.1 Company Overview
9.5 Ortho Clinical Diagnostics Holdings Ltd (Inactive)
9.5.1 Company Overview
9.6 Danaher Corp
9.6.1 Company Overview

10.1 Corporate Communications
10.1.1 Nov 05, 2025: Waardenburg Syndrome and Piebaldism
10.1.2 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.1.3 Oct 24, 2025: EU Invests in Umeå Research
10.1.4 Sep 10, 2025: NWO Grants €6.8 Million to META-IMMUNOTYPES Consortium Led by Dr. Garcia Vallejo
10.1.5 Aug 12, 2025: Markus Rohrwild Appointed New CEO of Gubra in a Planned Succession Process
10.1.6 Jun 12, 2025: Relief Therapeutics Announces Results of Annual General Meeting
10.2 Other Significant Developments
10.2.1 Nov 05, 2025: Skolkovo Launches Grant Support for Technological Leaders
10.2.2 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.2.3 Oct 24, 2025: EU Invests in Umeå Research
10.2.4 Sep 10, 2025: NWO Grants €6.8 Million to META-IMMUNOTYPES Consortium Led by Dr. Garcia Vallejo
10.3 Product News
10.3.1 Nov 17, 2025: ScreenCell Standardizes CTC Isolation Kits to Two Filtration Units
10.3.2 Nov 14, 2025: Scientists Invent New Method for Producing Platelet-Producing Cells from Stem Cells
10.3.3 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.3.4 Oct 30, 2025: FNCC RR Showcases Innovative Developments at All-Russian Exhibition
10.3.5 Oct 10, 2025: An International Project Employs 'Resurrected' Ancestral Enzymes for Cancer Prevention and Neurobiology Studies
10.3.6 Sep 19, 2025: Boditech Med Launches Advanced Diabetes Diagnostics at EASD 2025
10.3.7 Sep 08, 2025: New metabolic clock could help detect early signs of disease and accelerated aging
10.4 Research And Development
10.4.1 Nov 05, 2025: Skolkovo Launches Grant Support for Technological Leaders
10.4.2 Oct 10, 2025: An International Project Employs 'Resurrected' Ancestral Enzymes for Cancer Prevention and Neurobiology Studies
10.5 Strategy And Business Planning
10.5.1 Nov 17, 2025: UMA Joins Technological Platforms to Boost Innovation
10.5.2 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.5.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 the Analyst Consulting
11.3 Contact Us
11.4 Disclaimer

Table 1: Metabolic Disorders Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036
Table 2: Metabolic Disorders Market, EU5, Revenue ($m), USD Constant, 2024-2036
Table 3: Metabolic Disorders Market, EU5, Volume (Units), 2024-2036
Table 4: Metabolic Disorders Market, EU5, Volume (Units), 2024-2036
Table 5: Metabolic Disorders Market, EU5, Company Share by Revenue ($m), 2025
Table 6: Metabolic Disorders Market, France, Revenue ($m), USD Constant, 2024-2036
Table 7: Cholesterol Tests Market, France, Revenue ($m), USD Constant, 2024-2036
Table 8: Diabetes Assays Market, France, Revenue ($m), USD Constant, 2024-2036
Table 9: Metabolic Disorders Market, France, Volume (Units), 2024-2036
Table 10: Cholesterol Tests Market, France, Volume (Units), 2024-2036
Table 11: Diabetes Assays Market, France, Volume (Units), 2024-2036
Table 12: Metabolic Disorders Market, France, Average Price ($), 2024-2036
Table 13: Metabolic Disorders Market, France, Company Share by Revenue ($m), USD Constant, 2025
Table 14: Metabolic Disorders Market, France, Company Share by Revenue ($m), USD Constant, 2025
Table 15: Metabolic Disorders Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 16: Cholesterol Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 17: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 18: Metabolic Disorders Market, Germany, Volume (Units), 2024-2036
Table 19: Cholesterol Tests Market, Germany, Volume (Units), 2024-2036
Table 20: Diabetes Assays Market, Germany, Volume (Units), 2024-2036
Table 21: Metabolic Disorders Market, Germany, Average Price ($), 2024-2036
Table 22: Metabolic Disorders Market, Germany, Company Share by Revenue ($m), USD Constant, 2025
Table 23: Metabolic Disorders Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 24: Cholesterol Tests Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 25: Diabetes Assays Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 26: Metabolic Disorders Market, Italy, Volume (Units), 2024-2036
Table 27: Cholesterol Tests Market, Italy, Volume (Units), 2024-2036
Table 28: Diabetes Assays Market, Italy, Volume (Units), 2024-2036
Table 29: Metabolic Disorders Market, Italy, Average Price ($), 2024-2036
Table 30: Metabolic Disorders Market, Italy, Company Share by Revenue ($m), USD Constant, 2025
Table 31: Metabolic Disorders Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 32: Cholesterol Tests Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 33: Diabetes Assays Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 34: Metabolic Disorders Market, Spain, Volume (Units), 2024-2036
Table 35: Cholesterol Tests Market, Spain, Volume (Units), 2024-2036
Table 36: Diabetes Assays Market, Spain, Volume (Units), 2024-2036
Table 37: Metabolic Disorders Market, Spain, Average Price ($), 2024-2036
Table 38: Metabolic Disorders Market, Spain, Company Share by Revenue ($m), USD Constant, 2025
Table 39: Metabolic Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 40: Cholesterol Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 41: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 42: Metabolic Disorders Market, United Kingdom, Volume (Units), 2024-2036
Table 43: Cholesterol Tests Market, United Kingdom, Volume (Units), 2024-2036
Table 44: Diabetes Assays Market, United Kingdom, Volume (Units), 2024-2036
Table 45: Metabolic Disorders Market, United Kingdom, Average Price ($), 2024-2036
Table 46: Metabolic Disorders Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2025
Table 47: Metabolic Disorders Market Pipeline Products
Table 48: Metabolic Disorders - Pipeline Products by Stage of Development
Table 49: Metabolic Disorders Companies - Pipeline Products by Stage of Development
Table 50: Metabolic Disorders - Pipeline Products by Segment
Table 51: Metabolic Disorders - Pipeline Products by Territory
Table 52: Metabolic Disorders - Pipeline Products by Regulatory Path
Table 53: Metabolic Disorders - Pipeline Products by Estimated Approval Date
Table 54: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

Figure 1: Metabolic Disorders Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 2: Metabolic Disorders Market, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 3: Metabolic Disorders Market, EU5, Volume (Units), 2024-2036
Figure 4: Metabolic Disorders Market, EU5, Volume (Units), 2024-2036
Figure 5: Metabolic Disorders Market, EU5, Company Share (%), 2025
Figure 6: Metabolic Disorders Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 7: Cholesterol Tests Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 8: Diabetes Assays Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 9: Metabolic Disorders Market, France, Volume (Units), 2024-2036
Figure 10: Cholesterol Tests Market, France, Volume (Units), 2024-2036
Figure 11: Diabetes Assays Market, France, Volume (Units), 2024-2036
Figure 12: Metabolic Disorders Market, France, Company Share (%), 2025
Figure 13: Metabolic Disorders Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 14: Cholesterol Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 15: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 16: Metabolic Disorders Market, Germany, Volume (Units), 2024-2036
Figure 17: Cholesterol Tests Market, Germany, Volume (Units), 2024-2036
Figure 18: Diabetes Assays Market, Germany, Volume (Units), 2024-2036
Figure 19: Metabolic Disorders Market, Germany, Company Share (%), 2025
Figure 20: Metabolic Disorders Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 21: Cholesterol Tests Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 22: Diabetes Assays Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 23: Metabolic Disorders Market, Italy, Volume (Units), 2024-2036
Figure 24: Cholesterol Tests Market, Italy, Volume (Units), 2024-2036
Figure 25: Diabetes Assays Market, Italy, Volume (Units), 2024-2036
Figure 26: Metabolic Disorders Market, Italy, Company Share (%), 2025
Figure 27: Metabolic Disorders Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 28: Cholesterol Tests Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 29: Diabetes Assays Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 30: Metabolic Disorders Market, Spain, Volume (Units), 2024-2036
Figure 31: Cholesterol Tests Market, Spain, Volume (Units), 2024-2036
Figure 32: Diabetes Assays Market, Spain, Volume (Units), 2024-2036
Figure 33: Metabolic Disorders Market, Spain, Company Share (%), 2025
Figure 34: Metabolic Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 35: Cholesterol Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 36: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 37: Metabolic Disorders Market, United Kingdom, Volume (Units), 2024-2036
Figure 38: Cholesterol Tests Market, United Kingdom, Volume (Units), 2024-2036
Figure 39: Diabetes Assays Market, United Kingdom, Volume (Units), 2024-2036
Figure 40: Metabolic Disorders Market, United Kingdom, Company Share (%), 2025
Figure 41: Metabolic Disorders - Pipeline Products by Stage of Development
Figure 42: Metabolic Disorders - Pipeline Products by Segment
Figure 43: Metabolic Disorders - Pipeline Products by Territory
Figure 44: Metabolic Disorders - Pipeline Products by Regulatory Path
Figure 45: Metabolic Disorders - Pipeline Products by Estimated Approval Date